| Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users’ views G Bertier, M Hétu, Y Joly BMC medical genomics 9, 1-12, 2016 | 101 | 2016 |
| Genomics for all: international open science genomics projects and capacity building in the developing world M Hetu, K Koutouki, Y Joly Frontiers in Genetics 10, 95, 2019 | 20 | 2019 |
| Measuring the performance of international genomics research projects in fostering genomic capacity in the developing world M Hetu, Y Joly, K Koutouki New Genetics and Society 36 (4), 315-335, 2017 | 3 | 2017 |
| Burying the hatchet? How competition affects the performance benefits of diversity G Di Stefano, E Novelli, M Hetu Academy of Management Proceedings 2020 (1), 21050, 2020 | 1 | 2020 |
| A Contemporary Rereading of the Right to Withdraw Consent to Research in the Era of Biobanks M Hetu, Y Joly, BM Knoppers Lex Electronica 25, 109, 2020 | 1 | 2020 |
| La bibliométrie et l’innovation: l’étude de l’impact de la propriété intellectuelle sur le progrès scientifique M Hetu Ethics, Medicine and Public Health 4, 81-86, 2018 | 1 | 2018 |
| Essays on the Cross-Border Implications of Intellectual Property Rights Institutions M Hetu Jouy-en Josas, HEC, 2021 | | 2021 |
| Intellectual Property Rights and Market Entry Incentives: Evidence from the Pharmaceutical Industry M Hetu, D Mindruta, WG Mitchell Academy of Management Proceedings 2020 (1), 21551, 2020 | | 2020 |
| La médecine génomique en santé internationale: Le rôle des projets internationaux de science ouverte en génomique M Hétu | | 2016 |
| Rapport Final-Le médecin face aux nouvelles technologies dans le domaine médical: nouvelles responsabilités?(Final Report–Physicians and Emerging Technologies in the Medical … A Thorogood, A Rioux, C Fecteau, D Sinnett, E Kirby, G Stewart, ... | | 2012 |
| Track 8.5-Disclosure and Exclusion: The challenges of collaboration in Open Innovation D MINDRUTA, J BERCOVITZ, M HETU | | |
| Intellectual Property Rights and New Technology Development: How the Replacement Effect and Capabilities Influence Firm Investment Following a Reduction In IPR M Hetu, D Mindruta, W Mitchell | | |
Joly YannProfessor, Health law & bioethics, McGill在 mcgill.ca 的电子邮件经过验证
